JPRN-UMIN000029594
Completed
未知
Assessment of bone related bio-markers in patients with rheumatoid arthritis treated with Certolizumab pegol - Bone related bio-markers in rheumatoid arthritis
Graduate School of Medicine, Osaka University Department of Respiratory Medicine and Clinical Immunology0 sites40 target enrollmentOctober 17, 2017
Conditionsrheumatoid arthritis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- rheumatoid arthritis
- Sponsor
- Graduate School of Medicine, Osaka University Department of Respiratory Medicine and Clinical Immunology
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate CancerProstate CancerNCT00391690Novartis99
Completed
Not Applicable
Evaluation of Bone Metabolism Biomarkers in Periodontal DiseasesPeriodontal DiseasesNCT05702892Necmettin Erbakan University60
Not yet recruiting
Not Applicable
Polycystic ovarian syndrome & Chronic PeriodontitisHealth Condition 1: R888- Abnormal findings in other body fluids and substancesHealth Condition 2: E282- Polycystic ovarian syndromeCTRI/2019/09/021214SERB DST
Recruiting
Not Applicable
To study the effect of Terminalia chebula in osteoarthritis patients.CTRI/2013/08/003900Indian Council of Medical Research20
Active, not recruiting
Phase 1
Bone turnover markers as predictors of treatment break outcomeOsteoporosisMedDRA version: 19.0 Level: LLT Classification code 10031289 Term: Osteoporosis, unspecified System Organ Class: 100000004859Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2016-003110-27-DKBente Lomholt Langdahl, Dept. of Endocrinology and Internal Medicine, Aarhus University Hospital140